Lifeline Scientific, Inc Annual Financial Report (2872I)

TIDMLSI TIDMLSIC

RNS Number : 2872I

Lifeline Scientific, Inc

28 May 2014

Lifeline Scientific

("Lifeline" or the "Company")

Posting of Annual Report & Notice of AGM

Lifeline Scientific (AIM: LSIC, LSI), the transplantation technology company, confirms that the Annual Report and Accounts for the year ended 31 December 2013 ("2013 Annual Report and Accounts"), the Notice of the Annual General Meeting ("AGM") and a Form of Proxy were posted to shareholders on 23 May 2014.

The AGM is to be held at 8:30 am US CDT on 19 June 2014 at the Westin Hotel, 400 Park Boulevard, Itasca, IL 60143, USA.

A copy of the 2013 Annual Report and Accounts is available on the Company's website: www.lifeline-scientific.com

For further information, please contact:

 
 Lifeline Scientific, Inc.                                       www.lifeline-scientific.com 
 David Kravitz, CEO                                                     Tel: [phone] 
 Lisa Kieres, CFO                                                       Tel: [phone] 
 
 Panmure Gordon (UK) Limited                                        Tel: [phone] 
 Freddy Crossley/Fred Walsh (Corporate 
  Finance) 
 Adam Pollock (Corporate Broking) 
 
 Walbrook                                Tel: [phone] or [e-mail] 
 Paul McManus                                                       Mob: [phone] 
 Mike Wort                                                          Mob: [phone] 
 

About Lifeline Scientific Inc.

Lifeline Scientific, Inc. is a Chicago-based global medical technology company with regional offices in Brussels and Sao Paulo. The Company's focus is the development of innovative products that improve transplant outcomes and lower the overall costs of transplantation. Its lead product is the market-leading and clinically validated LifePort Kidney Transporter. Devices for preservation of the liver, pancreas, heart and lung are in late stage pre-clinical development. For more information please visit www.lifeline-scientific.com

About LifePort Kidney Transporter

Created with the challenges of organ recovery and transport in mind, LifePort Kidney Transporter is a proprietary medical device designed to provide improved kidney preservation, evaluation and transport prior to transplantation. Today, it is widely recognised as the world's leading machine preservation device for kidneys. Employed by surgeons in over 160 leading transplant programmes in 27 countries worldwide, LifePorts have successfully preserved over 47,000 kidneys indicated for clinical transplant. For more information please visit www.organ-recovery.com

Lifeline Scientific, Inc. Shares

As a US Company listed on the London Stock Exchange's AIM exchange, Lifeline Scientific, Inc. (AIM: LSIC, LSI) trades under two lines of stock. While affiliates of the Company are required to hold restricted (RegS) shares, all others may hold restricted or unrestricted shares. Unrestricted shares may be electronically traded through the CREST system. Both lines of stock have identical rights, preferences and privileges. Non-affiliates may transfer restricted shares to the unrestricted line after purchase through the Company's registrar. Total shares outstanding for the Company at this time are 19,446,959.

This information is provided by RNS

The company news service from the London Stock Exchange

END

ACSQKFDQABKDAPB